Inrom Building 2025: The Recovery Is Broad, but the Proof Year Is Still Ahead

Getting To Know The Company

Inrom is not a single-product story around paint, blocks, or adhesives. It is a broad Israeli building materials group that operates across a large part of the construction and renovation value chain, from Ytong and Alumalite in building solutions, through Carmit Mister Fix in finishing products, Nirlat in paints, and SP in plumbing systems. That matters, because the right way to read 2025 is not "Nirlat recovered" but "the whole group is growing again, while two bottlenecks still sit at the center of the story."

What is working right now? Revenue rose in 2025 to ILS 1.399 billion, EBITDA rose to ILS 341.5 million, and profit attributable to shareholders rose to ILS 156.1 million. All four segments grew, the balance sheet stayed strong, and net financial debt fell to just ILS 37.6 million. This is no longer a company that is merely trying to absorb the shock from the war damage at Nirlat.

What is still not clean? First, Nirlat has returned to activity levels, but not to the profitability levels it had before the damage in Nir Oz. Second, Inrom is entering a particularly heavy investment phase: the gypsum plant in Pardes Hanna is nearly complete after roughly ILS 225 million of investment, while a new block plant in Ashkelon was approved with an estimated cost of about ILS 240 million. So 2026 looks less like a harvest year and more like a proof year.

The first-screen read for investors should be simple: this is already a broad recovery story, not a single-site rescue story. But it is still not a clean operating leverage story, because part of profit and liquidity still reflects war compensation, part of the growth sits on assets that have not started contributing yet, and part of the improvement in building solutions comes through Alumalite, whose economics are not fully owned by Inrom common shareholders.

Four things a superficial read is likely to miss:

1. The 2025 recovery is more real than the headline suggests. Other income fell to ILS 85.0 million from ILS 107.4 million in 2024, yet operating profit still rose 40.2% to ILS 231.1 million. The operating improvement was strong enough to offset lower compensation support.

2. Nirlat is back in volume, not yet back in economics. Paint segment revenue rose 35.4% to ILS 400.3 million, but operating profit rose only 9.2% to ILS 64.7 million, and the segment's operating margin of about 16.2% still sits below the roughly 20% recorded in 2024.

3. The balance sheet is strong, but the cash picture is less comfortable than it looks. Cash flow from operations was ILS 232.9 million, but after reported CAPEX of about ILS 168.5 million, dividends to shareholders of ILS 69.9 million, dividends to minorities of ILS 4.5 million, and lease principal repayment of ILS 21.8 million, all-in cash flexibility was negative before new financing.

4. Not every shekel of building solutions growth belongs to Inrom shareholders. Alumalite expanded the group, but it is only 55% owned, and profit attributable to non-controlling interests reached ILS 12.9 million in 2025. That means part of the segment upside remains below the listed common-shareholder layer.

To understand the group quickly, it helps to start with the economic map:

From a market perspective, Inrom trades at roughly ILS 3.8 billion of market value, with daily trading turnover in the low millions of shekels, so liquidity is not the practical blocker here. What the market has to decide is not whether the company is growing again, but how much of 2025 already reflects a clean earnings structure and how much still reflects a transition between recovery and investment execution.

Events And Triggers

The shift from defense to offense

First trigger: Inrom is no longer operating only in damage-control mode. On the capital structure side, it completed its first bond issuance in October 2025, raising ILS 168 million in a new series at a 4.56% stated coupon, non-linked, and rated ilAA-. This is not just funding diversification. It is a statement that the group has moved into a growth-financing phase.

Second trigger: The gypsum plant in Pardes Hanna has effectively moved from planning into commissioning. By the end of 2025, about ILS 206 million had already been invested out of a total expected investment of roughly ILS 225 million, and all structural and infrastructure works had been completed. In practical terms, 2025 already carries the financing and execution burden, but not yet the business contribution.

Third trigger: In parallel, the board approved a new block plant in Ashkelon with an estimated investment of about ILS 240 million. That sharpens the strategic direction, deeper manufacturing in core markets, but it also extends the duration of the current investment cycle.

Structural changes shaping the year

2025 did not arrive on a clean slate. In February 2024 the company raised about ILS 225 million of equity, in October 2024 Benjamin Baron completed off-market share purchases and reached about 20.78% ownership, in May 2024 the group completed the Alumalite control acquisition, and in December 2025 Ehud Danoch entered as group CEO.

Taken together, that creates a clear frame. In less than two years, Inrom moved from equity raising, through a strategic acquisition, into bond financing and a management transition. This is not a company harvesting a stable installed base. It is a company rebuilding its growth profile, which is why 2025 should be read as a strong transition stage, not as an end-state.

Nirlat is still the key operating event

Nirlat returned to ongoing activity, but the story is broader than simple revenue recovery. In August 2025 it signed an agreement with the Israeli Property Tax Compensation Fund under which it is to receive ILS 215.6 million plus VAT beyond the ILS 100 million advance paid in October 2023, and another ILS 57.8 million advance was paid in August 2025. By year-end 2025, Nirlat had received cumulative advances of about ILS 318 million for direct and indirect damages.

That money matters not only because it softens the hit. It directly shapes how the market reads earnings, the balance sheet, and cash flow. Any bullish interpretation of Nirlat therefore has to separate business recovery from state compensation.

Efficiency, Profitability, And Competition

Growth is broad, but the quality of growth differs by segment

Inrom closed 2025 with 25.4% revenue growth to ILS 1.399 billion. That did not come from a single engine. Building Solutions grew 18.7%, Finishing Products grew 27.6%, Paint Products grew 35.4%, and Plumbing Systems grew 14.4%.

But the quality of that growth is not the same. Building Solutions still carries a base effect from Alumalite, which was first consolidated only from May 2024, so part of the year-on-year comparison is simply a fuller year of ownership. In finishing products and plumbing, the read looks cleaner and more tied to actual demand recovery and execution. In paints, volume is back, but economics are not.

The margin gaps are what really matter. In Building Solutions, operating profit nearly doubled to ILS 60.9 million, so this is not just a revenue story. In Finishing Products, operating profit rose to ILS 85.8 million, and the segment remains a high-quality earnings engine even before gypsum contributes. Plumbing is smaller, but steady. The outlier is Paints, where revenue recovered the fastest, but profitability improved far more slowly.

Nirlat: materially better than the 2024 chaos, still not normal

The Paint Products segment closed 2025 with revenue of ILS 400.3 million and gross profit of ILS 92.8 million, implying a gross margin of about 23%. That is a sharp recovery versus 2024, but the company itself states that Nirlat has not yet returned to the profitability levels it had before the war.

That distinction is critical. Nirlat succeeded in establishing production and storage capabilities in Be'er Sheva at volumes close to those of its core building-paint products before October 7, 2023. But it is doing so within a less efficient, more labor-intensive cost structure. The problem is no longer product availability. The problem is the economics of producing under this temporary setup.

For investors, that means revenue alone is not enough. The real test is whether margin can recover without leaning on compensation and without the current temporary production structure. Until that happens, Nirlat remains an operating recovery story, not a full normalization story.

Lower compensation actually makes the operating recovery more impressive

The group recorded other income of ILS 85.0 million in 2025, versus ILS 107.4 million in 2024. That included ILS 70.8 million of indirect war compensation and ILS 9.7 million of net direct compensation related to the Nirlat site. So even with less support from other income, operating profit rose sharply.

That matters, because it means 2025 is still not compensation-free, but it is also not relying on compensation more than the prior year. In fact, the opposite is true. Once the roughly ILS 22.5 million drop in other income is taken into account, the underlying operating gain looks even stronger.

The competitive position is real, but not costless

Inrom clearly has several strengths: a very broad brand and product portfolio, a diversified customer base with no material single customer dependence, and deep penetration into Israeli construction and renovation channels. In 2025, about 51% of sales came from trade houses and retail networks, about 47% from contractors and construction companies, while exports remained negligible at about 1% of sales. This is a very domestic story.

That strength also creates clear sensitivity. Inrom is exposed to construction activity, renovation demand, customer credit conditions, and labor availability in the Israeli building market. So even when the group shows a solid operating moat, it remains a moat inside a highly local cycle.

Cash Flow, Debt, And Capital Structure

The cash picture: strong operationally, tighter after real uses

The right way to read 2025 is to hold two cash views at the same time. On a normalized cash generation basis, the existing business looks strong: cash flow from operations reached ILS 232.9 million, after only about ILS 29.2 million of working-capital effects.

But on an all-in cash flexibility basis, meaning after actual cash uses, the picture is less generous. If operating cash flow is reduced by reported CAPEX of about ILS 168.5 million, dividends to shareholders of ILS 69.9 million, dividends to non-controlling interests of ILS 4.5 million, and lease principal repayment of ILS 21.8 million, the result is still about ILS 31.8 million negative before new financing.

That framing choice matters. This bridge uses lease principal, not total lease-related cash outflow. If total negative cash flow for leases, ILS 34.7 million, is used instead, the picture becomes even more conservative. Anyone reading 2025 through EBITDA alone is therefore missing the fact that this was still an investment year, not a harvest year.

The balance sheet is strong, but part of the strength is also compensation-related

To Inrom's credit, the balance sheet is genuinely strong. The equity ratio reached about 61% at year-end 2025, total equity stood at ILS 1.312 billion, net financial debt fell to ILS 37.6 million, and the group had total bank credit lines of ILS 641 million, of which only around ILS 47 million was utilized including guarantees.

The bond covenants are also very far from stress. Equity attributable to shareholders stood at about ILS 1.23 billion against a ILS 500 million threshold for coupon step-up, and the equity-to-balance-sheet ratio stood at 61.23% against a 22.5% threshold. The segment-level bank covenants also look comfortably met.

Still, it is important to be precise. At year-end 2025, accrued income included about ILS 101.1 million, of which roughly ILS 98 million was compensation receivable from the state, net of advances. Part of the year-end balance sheet cushion therefore reflects war-related receivables, not only ordinary operating cash generation.

Working capital: sales growth, but also customer financing

Receivables rose to ILS 560.7 million from ILS 500.2 million, and average customer credit stood at about 126 days, versus about 86 days average supplier credit. In other words, Inrom benefits from a broad distribution system and solid customer reach, but its growth still consumes working capital.

There is some good news here as well. About 74% of receivables were covered by trade credit insurance at year-end, and the company states that it has no material dependence on any single customer. That reduces the risk, but it does not change the fact that the balance sheet is still carrying part of the growth burden.

Outlook

2026 looks like a proof year

If next year needs a label, it is not a breakout year and not a stabilization year. It looks much more like a proof year. The reason is simple: the three core strategic threads, Nirlat, the gypsum plant, and the future block plant, have not yet all reached the point where they can be read cleanly.

At Nirlat, the company still says it cannot fully estimate the total investment that will be required for the new site or the full future impact of the war. At the gypsum plant, most of the investment is already in the numbers, while the earnings contribution is still absent. At the new block plant, this is still a multi-year investment decision, not a near-term earnings engine.

What has to happen for the read to improve

The first checkpoint is the first part of 2026, when the gypsum plant needs to move from technical start-up in the second quarter into commercial contribution. A launch announcement is not enough. The business needs to show real sales and a margin profile that strengthens, rather than dilutes, Carmit's economics.

The second checkpoint is Nirlat. Here the market will not be asking whether supply is back. It will be asking whether margin is coming back. If the Paint Products segment keeps growing revenue without rebuilding profitability, the market may conclude that the return was only to volume, not to economics.

The third checkpoint is capital allocation discipline. The company explicitly says that after Ehud Danoch's appointment, the group's targets and business strategy are under review and may be adjusted. That is a small sentence with a large implication: strategy is not fully locked, and new management may require a more explicit return test from the current investment cycle.

What the market may read incorrectly

The risk in the bullish interpretation is assuming that 2025 already represents the earnings structure of 2026 and 2027. That is too early. The year still contains three temporary elements: war compensation, pre-contribution investment costs, and a temporary production structure at Nirlat.

But the cautious interpretation can also go too far. Anyone focusing only on compensation is missing that the improvement was not purely accounting. Compensation was lower than in 2024, yet gross profit, operating profit, and EBITDA all rose sharply. The right read sits in the middle: this is a real recovery, but it has not yet become a fully clean earnings story.

Risks

Nirlat is both an asset and a source of uncertainty

The company says it cannot estimate the full future impact of the war on Nirlat or the full investment requirement for rebuilding the new plant. That is still the central yellow flag. Nirlat is back in production, but as long as the permanent site is not yet rebuilt and part of the earnings still depends on compensation, full normalization remains out of reach.

In addition, about 74% of raw materials and packaging purchases in the Paint Products segment are sourced abroad, mainly in Europe and China, and the company itself highlights exposure to the dollar and euro, even if it does use short-dated hedging from time to time. So even after the plant returns, Nirlat is likely to remain a more sensitive business than the other segments.

The investment program can create value, but it can also weigh on the story

The gypsum plant is supposed to expand Carmit's solution set, and the new block plant is meant to strengthen the Building Solutions segment. That is the upside. The other side is that investments in the hundreds of millions of shekels do not generate returns from day one, especially when the company keeps paying dividends in parallel.

Every capital move here therefore has to be tested in both directions. New plants may strengthen competitive position, but in the near term they burden cash, create delay risk, and lengthen the proof period.

Governance and related-party exposure

This risk is not new, but it has not disappeared. In 2025 the group conducted transactions with a company owned by Benjamin Baron for grey cement purchases and land transportation services totaling about ILS 4.5 million. After the balance-sheet date, the board approved an engagement with Sapir Baron Danoch as director across all five subsidiaries at one-third employment scope and monthly management fees of ILS 33,000 plus VAT and expenses, subject to shareholder approval, while also approving an amendment to the company's compensation policy.

This does not automatically mean governance failure. But it does mean the market may continue demanding higher discipline around compensation, governance, and related-party dealings. In a company going through a heavy investment cycle and a management transition, this is a material issue rather than a side note.

Short Interest

The short-interest position does not currently suggest an unusually aggressive attack on the story. At the end of March 2026, short float stood at only 0.69%, while SIR stood at 2.3 days, slightly above the sector average in SIR but nowhere near crowded-short territory. The more interesting point is the direction: in January 2026 short float had still been 1.81%, and it has since fallen sharply.

The market read here is that skepticism has not disappeared, but neither has it turned into a heavy conviction short. That is usually consistent with a company whose story is improving, but still needs proof.

Conclusions

Inrom exits 2025 as a stronger company than it looked at the start of the year. The recovery is already visible across all segments, the balance sheet remains strong, and Nirlat is far removed from the position it was in right after the damage at Nir Oz. The main blocker is that this strong year still mixes war compensation, a temporary production structure at Nirlat, and a heavy investment cycle whose full contribution is not yet visible. What will drive the market read over the next few quarters is not whether 2025 was good, but whether 2026 proves that the improvement can move from volume and projects into clean returns.

Current thesis in one line: Inrom is already back to broad-based growth, but the path to a cleaner story runs through margin recovery at Nirlat, commercial ramp-up at the gypsum plant, and capital discipline within an ambitious investment cycle.

What changed versus the prior understanding: this is no longer just a Nirlat recovery story. It is now a group-wide recovery story, but one that requires sharper separation between true operating improvement and the profit and balance-sheet support that still come from compensation and financing.

The strongest counter-thesis: 2025 may still overstate normalized earning power, because Nirlat has not yet returned to a normal cost structure, while the gypsum and block projects could be delayed or deliver weaker-than-expected returns.

What could change the market interpretation in the short to medium term: clean commercial start-up at the gypsum plant in 2026, continued margin improvement in Paint Products without heavier reliance on compensation, and signs that the new management team is staying disciplined on both dividends and CAPEX.

Why this matters: Inrom is moving from recovery into return-on-investment proof, and that is the point where the market starts asking whether operating strength is truly turning into cash generation and accessible value for common shareholders.

If Inrom can show over the next 2 to 4 quarters that Nirlat is rebuilding margin, the gypsum plant is beginning to contribute commercially, and the investment cycle remains disciplined on a cash basis, the market read can improve meaningfully. If margin at Nirlat stays stuck, CAPEX continues to run ahead of returns, and dividend policy remains aggressive, the market may stay cautious even against good reported numbers.